Want to see GB:SYNC full AI Analyst Report?
SYNC Stock Chart & Stats
107.00 p
-0.80 p(-0.74%)
At close: 4:00 PM EDT
107.00 p
-0.80 p(-0.74%)
Day’s Range― - ―
52-Week Range86.80 p - 117.00 p
Previous CloseN/A
Volume190.55K
Average Volume (3M)559.51K
Market Cap
£686.04M
Enterprise Value589.73M
Total Cash (Recent Filing)£1.92M
Total Debt (Recent Filing)£0.00
Price to Earnings (P/E)―
Beta0.39
Next Earnings
Nov 12, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding608,193,050
10 Day Avg. Volume325,856
30 Day Avg. Volume559,509
Financial Highlights & Ratios
PEG Ratio0.65
Price to Book (P/B)0.52
Price to Sales (P/S)9.39
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
£189.00Price Target Upside76.64% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)<0.01
Revenue Forecast (FY)£49.14M
Bulls Say, Bears Say
Bulls Say
Debt-free Balance SheetA debt-free structure reduces refinancing and interest-rate risk while preserving flexibility to support portfolio companies. The substantial equity base also provides resilience through biotechnology development cycles, where investment returns can take several years to materialize.
Recent Positive Operating Cash FlowPositive operating cash flow in the three most recent annual periods provides some internal funding support and reduces reliance on external financing. Although the record is uneven, the recent direction offers a foundation for sustaining operations and portfolio commitments.
Long-term Life-sciences Investment ModelThe company-builder model can create durable value by combining capital, strategic guidance and development support across innovative therapies and technologies. Exposure to multiple portfolio companies may also broaden participation in long-term life-sciences growth.
Bears Say
Persistent Profitability WeaknessLosses across the two latest fiscal years show that the capital base is not consistently generating profits. Continued negative earnings can constrain reinvestment capacity and make results dependent on portfolio valuation changes or future investment realizations.
Declining And Volatile RevenueA sharp decline after an earlier recovery reduces visibility into recurring income and indicates an uneven earnings profile. For an investment company, weak revenue consistency can reflect limited realization activity and dependence on portfolio milestones rather than a stable operating stream.
Free Cash Flow DeteriorationThe latest loss of free cash flow weakens cash conversion and may increase dependence on asset sales, distributions or capital-market access to fund commitments. Earlier negative operating cash flow reinforces the risk that cash generation will remain inconsistent.
Syncona Shs GBP News
SYNC FAQ
What was Syncona Shs GBP ’s price range in the past 12 months?
Syncona Shs GBP lowest share price was 86.80 p and its highest was 117.00 p in the past 12 months.
What is Syncona Shs GBP ’s market cap?
Syncona Shs GBP ’s market cap is £686.04M.
When is Syncona Shs GBP ’s upcoming earnings report date?
Syncona Shs GBP ’s upcoming earnings report date is Nov 12, 2026 which is in 68 days.
How were Syncona Shs GBP ’s earnings last quarter?
Syncona Shs GBP released its earnings results on Jun 18, 2026. The company reported 0.027 p earnings per share for the quarter.
Is Syncona Shs GBP overvalued?
According to Wall Street analysts Syncona Shs GBP ’s price is currently Undervalued.
Does Syncona Shs GBP pay dividends?
Syncona Shs GBP pays a Annually dividend of 2.3 p which represents an annual dividend yield of N/A. See more information on Syncona Shs GBP dividends here
What is Syncona Shs GBP ’s EPS estimate?
Syncona Shs GBP ’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Syncona Shs GBP have?
Syncona Shs GBP has 608,193,050 shares outstanding.
What happened to Syncona Shs GBP ’s price movement after its last earnings report?
Syncona Shs GBP reported an EPS of 0.027 p in its last earnings report. Following the earnings report the stock price went up 2.99%.
Which hedge fund is a major shareholder of Syncona Shs GBP ?
Currently, no hedge funds are holding shares in GB:SYNC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Syncona Shs GBP Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
£189.00 (76.64% Upside)
£189.00 (76.64% Upside)
Insider Transactions
Bought Shares
Worth £16.0K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
20.51%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-1.14%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Syncona Shs GBP
Syncona Ltd. is a closed-end investment fund, which engages in delivering returns from investments in long and alternative investment funds across multiple asset classes and targets. Its portfolio includes commercial companies, late-stage clinical companies, clinical companies, and pre-clinical companies. The company was founded on August 14, 2012 and is headquartered in St. Peter Port, the United Kingdom.
SYNC Stock 12 Month Forecast
Average Price Target
189.00 p
▲(76.64% Upside)
Technical Analysis
Ashmore Group PLC
―
Molten Ventures
―
IP Group plc
―
Mercia Asset Management
―
Caledonia Investments
―